![logo](/logos/EVGN.webp)
Evogene Ltd.
NASDAQ:EVGN
2.96 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Evogene Ltd. |
Symbool | EVGN |
Munteenheid | USD |
Prijs | 2.96 |
Beurswaarde | 14,973,124 |
Dividendpercentage | 0% |
52-weken bereik | 2.91 - 10.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ofer Haviv CPA |
Website | https://www.evogene.com |
An error occurred while fetching data.
Over Evogene Ltd.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)